Abstract

Topical Treatment of Primary Focal Hyperhidrosis, Part 2

Author(s): Zur Eyal

Issue: Mar/Apr 2019 - Volume 23, Number 2

Page(s): 94-104

Download in electronic PDF format for $75
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 1
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 2
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 3
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 4
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 5
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 6
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 7
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 8
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 9
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 10
  • Topical Treatment of Primary Focal Hyperhidrosis, Part 2 Page 11

Note: Electronic version includes errata or revisions.

Abstract

This represents part 2 of a 2-part article on the topic of primary focal hyperhidrosis. Part 1, which was published in the International Journal of Pharmaceutical Compounding’s January/February 2019 issue, provided a comprehensive review of the active pharmaceutical ingredients aluminum salts and methenamine in the treatment of primary focal hyperhidrosis. Part 2 provides a comprehensive review of the active pharmaceutical ingredients glycopyrronium salts and oxybutynin chloride in the treatment of primary focal hyperhidrosis.

Related Keywords

  • primary focal hyperhidrosis
  • excess sweating
  • exocrine sweat glands
  • sympathetic nervous system
  • topical preparations
  • aluminum salts
  • methenamine
  • glycopyrronium salts
  • glycopyrrolate
  • oxybutynin chloride
  • formulations
  • anticholinergic agents
  • antihidrotic agents
  • muscanergic receptors
  • eccrine glands
  • dosage forms
  • face
  • axilla
  • hand
  • foot
  • feet
  • patient satisfaction

Related Categories

  • DERMATOLOGY
  • FORMULATIONS
  • ADVERSE DRUG EVENTS
  • DOSAGE FORMS/DRUG CARRIERS
  • NEUROLOGY

Printer-Friendly Version

Related Articles from IJPC

Issue/Page
View/Buy		 Title/Author
(Click for Abstract / Details / Purchase)
Mar/Apr 2019
Pg. 94-104
Topical Treatment of Primary Focal Hyperhidrosis, Part 2
Author(s): Zur Eyal
Jan/Feb 2019
Pg. 23-31
Topical Treatment of Primary Focal Hyperhidrosis, Part 1
Author(s): Zur Eyal
Jan/Feb 2001
Pg. 28-29
Topical Therapy for Localized Hyperhidrosis
Author(s): Glasnapp Andrew
Jul/Aug 2004
Pg. 269-274
Current Topical Treatments in Wound Healing - Part 1
Author(s): Helmke Christopher D
Jul/Aug 2019
Pg. 351
Erratum: Zur E. Topical Treatment of Primary Focal Hyperhidrosis, Part 2. IJPC 2019; 23(2):94-104.
Author(s):
Jul/Aug 2003
Pg. 266-270
Sensitization Therapy for Warts
Author(s): Kuntz Rachael
Jan/Feb 2020
Pg. 7-12
Primary Engineering Controls in Pharmaceutical Compounding, Part 2: Biosafety Cabinets
Author(s): Mulder Kyle
Sep/Oct 2015
Pg. 357-365
Novel Approaches to Topical Psoriasis Therapy
Author(s): Koyama Gregory, Liu Jenny, Scaffidi Alyse, Khazraee Maryam, Epstein Benjamin
Jul/Aug 2010
Pg. 322-326
Basics of Compounding: Basics of Compounding with Organic Salts
Author(s): Allen Loyd V Jr
Mar/Apr 2011
Pg. 146-153
Basics of Compounding: Basics of Compounding with Inorganic Salts
Author(s): Allen Loyd V Jr
Mar/Apr 2011
Pg. 160
Hank's Balanced Salt Solution (Stock Solution)
Author(s): Allen Loyd V Jr
Jul/Aug 2005
Pg. 284-290
Considerations for Choosing a Primary Engineering Control for Compounding Sterile Products
Author(s): Wagner James T
Jan/Feb 2022
Pg. 52
Aluminum Chloride 6.25% in Anhydrous Alcohol
Author(s): Allen Loyd V Jr
Jul/Aug 2003
Pg. 288-291
Basics of Compounding for Raynaud's Disease
Author(s): Glasnapp Andrew
Mar/Apr 2016
Pg. 164-166
Long-term Stability of Zonisamide, Amitriptyline, and Glycopyrrolate in Extemporaneously Prepared Liquid-dosage Forms at Two Temperatures
Author(s): Nahata Milap C
Nov/Dec 2019
Pg. 447-452
Primary Engineering Controls in Pharmaceutical Compounding, Part 1: Unidirectional-airflow Workstations, Compounding Aseptic Isolators, and Compounding Aseptic Containment Isolators
Author(s): Mulder Kyle
Sep/Oct 2019
Pg. 366-375
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 3
Author(s): Zur Eyal
Jul/Aug 2019
Pg. 288-293
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 2
Author(s): Zur Eyal
May/Jun 2019
Pg. 200-207
Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1
Author(s): Zur Eyal
Nov/Dec 2011
Pg. 458-463
Infantile Hemangiomas, Part 2: Topical Treatment with Beta Blockers
Author(s): Zur Eyal